CURIS, INC. Royalty Guarantees, Commitments, Amount
CURIS, INC. (CRIS) had Royalty Guarantees, Commitments, Amount of $31.33 million as of 2024-03-31, per its 10-Q filed 2024-11-14.
Financial Statements › Notes
us-gaap:RoyaltyGuaranteesCommitmentsAmount · last filed 2025-03-31
- 2024-03-31: Royalty Guarantees, Commitments, Amount $31.33M.
- 2023-12-31: Royalty Guarantees, Commitments, Amount $34.10M.
- 2022-12-31: Royalty Guarantees, Commitments, Amount $43.23M.
| Period end | Royalty Guarantees, Commitments, Amount |
|---|---|
| 2024-03-31 | $31.33M 10-Q · filed 2024-11-14 |
| 2023-12-31 | $34.10M 10-K · filed 2025-03-31 |
| 2022-12-31 | $43.23M 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |